HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kentaro Miyake Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

5/2020Comparison of the Efficacy of EGFR Tyrosine Kinase Inhibitors Erlotinib and Low-dose Osimertinib on a PC-9-GFP EGFR Mutant Non-small-cell Lung Cancer Growing in the Brain of Nude Mice.
4/2019Osimertinib Regresses an EGFR-Mutant Cisplatinum- Resistant Lung Adenocarcinoma Growing in the Brain in Nude Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kentaro Miyake Research Topics

Disease

78Neoplasms (Cancer)
04/2023 - 01/2017
18Sarcoma (Soft Tissue Sarcoma)
01/2020 - 01/2017
17Neoplasm Metastasis (Metastasis)
08/2023 - 09/2017
16Pancreatic Neoplasms (Pancreatic Cancer)
04/2023 - 05/2017
15Osteosarcoma (Osteogenic Sarcoma)
07/2021 - 01/2017
7Liposarcoma
07/2020 - 01/2018
7Ewing Sarcoma (Sarcoma, Ewing)
05/2019 - 05/2017
6Melanoma (Melanoma, Malignant)
11/2020 - 10/2017
5Colonic Neoplasms (Colon Cancer)
08/2023 - 07/2019
4Lymphatic Metastasis
04/2023 - 02/2022
4Necrosis
02/2023 - 09/2019
4Adenocarcinoma
02/2021 - 05/2017
3Breast Neoplasms (Breast Cancer)
05/2020 - 02/2019
3Synovial Sarcoma (Synovioma)
06/2019 - 04/2018
2Klatskin Tumor
06/2024 - 04/2022
2Biliary Tract Neoplasms (Biliary Tract Cancer)
04/2023 - 08/2021
2Cholangiocarcinoma
02/2023 - 08/2021
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2020 - 04/2019
2Leiomyosarcoma
01/2019 - 01/2019
2Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2019 - 01/2017
2Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
06/2018 - 01/2018
1Stomach Neoplasms (Stomach Cancer)
02/2023
1Inflammation (Inflammations)
02/2023
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2023
1Myocardial Infarction
01/2023
1Pancreatic Fistula (Pancreatic Fistulas)
01/2023
1Neuroendocrine Tumors (Neuroendocrine Tumor)
12/2021
1Primitive Neuroectodermal Tumors (PNET)
12/2021
1Anaphylaxis (Anaphylactic Shock)
10/2021
1Margins of Excision
08/2021
1Lung Neoplasms (Lung Cancer)
02/2021
1Urinary Bladder Neoplasms (Bladder Cancer)
11/2020
1Hemorrhage
05/2020

Drug/Important Bio-Agent (IBA)

32Doxorubicin (Adriamycin)FDA LinkGeneric
07/2021 - 06/2017
25L-methionine gamma-lyaseIBA
08/2023 - 01/2017
17Methionine (L-Methionine)FDA Link
02/2023 - 01/2017
15GemcitabineFDA Link
04/2023 - 11/2017
11Temozolomide (Temodar)FDA LinkGeneric
07/2020 - 09/2017
8pazopanibFDA Link
07/2020 - 01/2017
7Docetaxel (Taxotere)FDA Link
07/2020 - 11/2017
6Red Fluorescent ProteinIBA
08/2023 - 05/2017
6palbociclibIBA
07/2021 - 01/2018
5Green Fluorescent ProteinsIBA
02/2021 - 05/2017
5eribulinFDA Link
07/2020 - 01/2018
5TrabectedinIBA
07/2020 - 09/2017
5olaratumabIBA
09/2019 - 01/2019
4Irinotecan (Camptosar)FDA LinkGeneric
05/2019 - 11/2017
4130-nm albumin-bound paclitaxelIBA
03/2019 - 01/2017
3Fluorouracil (Carac)FDA LinkGeneric
02/2023 - 09/2019
3Histones (Histone)IBA
04/2022 - 12/2020
3regorafenibIBA
11/2020 - 01/2018
3Proteins (Proteins, Gene)FDA Link
11/2020 - 12/2017
3Caffeine (No Doz)FDA LinkGeneric
02/2020 - 10/2018
2Lysine (L-Lysine)FDA Link
04/2022 - 01/2022
2Paclitaxel (Taxol)FDA LinkGeneric
10/2021 - 05/2020
2EverolimusFDA Link
07/2021 - 09/2019
2Cyclin-Dependent Kinase 4IBA
07/2021 - 11/2017
2AntigensIBA
02/2021 - 11/2020
2Drug CombinationsIBA
11/2020 - 09/2019
2ErbB Receptors (EGF Receptor)IBA
05/2020 - 04/2019
2osimertinibIBA
05/2020 - 04/2019
2Tyrosine Kinase InhibitorsIBA
05/2020 - 04/2019
2Sunitinib (Sutent)FDA Link
09/2019 - 01/2018
2Sorafenib (BAY 43-9006)FDA Link
09/2019 - 08/2019
2Fluorescent Dyes (Fluorescent Probes)IBA
12/2018 - 04/2018
2Imatinib Mesylate (Gleevec)FDA Link
06/2018 - 01/2018
2LyasesIBA
01/2018 - 01/2017
1N-acetyltalosaminuronic acid (NAT)IBA
04/2023
1Indicators and Reagents (Reagents)IBA
02/2023
1Hemoglobins (Hemoglobin)IBA
02/2023
1omega-Chloroacetophenone (Mace)IBA
01/2023
1Nicorandil (SG 75)IBA
01/2023
1BismuthIBA
04/2022
1Carboplatin (JM8)FDA LinkGeneric
10/2021
1BilirubinIBA
08/2021
1MTOR InhibitorsIBA
07/2021
1TOR Serine-Threonine KinasesIBA
07/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021
1histone H3 trimethyl Lys4IBA
12/2020
1PlasticsIBA
12/2020
1LigandsIBA
11/2020
1tigatuzumabIBA
11/2020

Therapy/Procedure

49Therapeutics
02/2023 - 01/2017
20Drug Therapy (Chemotherapy)
06/2024 - 11/2017
7Neoadjuvant Therapy
04/2023 - 09/2017
6Aftercare (After-Treatment)
05/2020 - 01/2017
3Oral Administration
06/2018 - 01/2018
2Radiotherapy
04/2023 - 02/2023
2Absorbable Gelatin Sponge
01/2021 - 12/2020
2Pancreaticoduodenectomy
05/2020 - 12/2019
2Laparotomy
06/2018 - 01/2018
2Immunotherapy
09/2017 - 06/2017
1Chemoradiotherapy
06/2024
1Percutaneous Coronary Intervention
01/2023
1Perioperative Period
01/2023
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2023
1Length of Stay
01/2023
1Pancreatectomy
12/2021
1Pancreaticojejunostomy
05/2020
1Gastric Bypass (Roux-en-Y Gastric Bypass)
05/2020